The Federal Trade Commission (FTC) has revealed that nearly 160,000 Americans may be eligible for a refund due to potential deception by the nation’s largest LASIK chain, LCA-Vision, which operates under the brand names LasikPlus and Joffe MediCenter.
The company has agreed to pay $1.25 million to settle claims made by the FTC regarding deceptive bait-and-switch advertising practices. According to the FTC, LCA-Vision used misleading advertising to create the impression that LASIK surgery could be obtained for as low as $300 per eye.
However, the majority of consumers did not qualify for this advertised promotional price, resulting in wasted time and confusion among those seeking affordable vision correction.
Victim of Damaging LASIK (Credits: Gregory Zeuthen Law Office)
The FTC alleges that only 6.5% of individuals who attended LASIK consultations were eligible for the $300 promotional price for both eyes. To qualify, individuals needed to have near-normal vision, sufficient for driving without glasses.
For the rest of the prospective LASIK patients, the actual cost typically ranged between $1,800 and $2,295 per eye, a stark contrast to the advertised rate.
Furthermore, some advertisements by LCA-Vision failed to disclose explicitly that the $300 price was per eye, contributing to a lack of transparency and potential confusion among consumers.
The settlement of $1.25 million aims to address these deceptive advertising practices and provide compensation to consumers who may have been misled by the LASIK chain’s promotional strategies.
The FTC emphasized that individuals wasted their time attending LASIK consultations, only to find out that the surgery would cost significantly more than initially indicated.
LASIK surgery is a popular vision correction procedure that uses laser technology to reshape the cornea, improving vision for individuals with refractive errors like nearsightedness, farsightedness, and astigmatism.
However, the cost of LASIK surgery can vary based on factors such as the surgeon’s experience, technology used, and the specific needs of the patient.
Deceptive advertising in the healthcare industry, including elective procedures like LASIK, can erode consumer trust and lead to dissatisfaction among individuals seeking these services.
The FTC’s action against LCA-Vision underscores the importance of transparent and truthful advertising to ensure that consumers can make informed decisions about their healthcare options.
Consumers who attended LASIK consultations with LCA-Vision, specifically those who were misled by the advertised $300 per eye price, may now be eligible for a refund.
The settlement serves as a reminder to businesses in the healthcare sector to prioritize honesty and clarity in their advertising practices to build and maintain trust with consumers.
In conclusion, the FTC’s settlement with LCA-Vision highlights the consequences of deceptive advertising in the LASIK industry and seeks to provide compensation to affected consumers.
As the nation’s largest LASIK chain, LCA-Vision’s case serves as a cautionary tale for businesses operating in the healthcare sector, emphasizing the importance of transparent and accurate communication to build and maintain trust among consumers.
